Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitiligo Treatment by Targeting TYK2 Mediated Responses Prospective Multicentric Double Blind Interventional Study

NCT06327321 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT06327321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06327321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitiligo Treatment by Targeting TYK2 Mediated Responses Prospective Multicentric Double Blind Interventional Study
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 5, 2024
Completion date
July 5, 2027
Enrollment
128 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo, generalized